Xi'an International Medical Investment Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Xi'an International Medical Investment kazanç ve gelirin sırasıyla yıllık 104.9% ve 21.6% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 128.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 8.2% olacağı tahmin edilmektedir.

Anahtar bilgiler

104.9%

Kazanç büyüme oranı

128.4%

EPS büyüme oranı

Healthcare kazanç büyümesi	23.0%
Gelir büyüme oranı	21.6%
Gelecekteki özkaynak getirisi	8.2%
Analist kapsamı	Low
Son güncelleme	29 Oct 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt

Nov 21

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Oct 01

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Jul 16

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Jun 20

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Mar 25

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Feb 28

Kazanç ve Gelir Büyüme Tahminleri

SZSE:000516 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	7,761	381	N/A	1,206	1
12/31/2025	7,077	320	N/A	1,351	2
12/31/2024	5,478	100	N/A	652	1
9/30/2024	4,880	-358	419	1,022	N/A
6/30/2024	4,829	-320	504	1,203	N/A
3/31/2024	4,732	-399	510	1,084	N/A
12/31/2023	4,618	-368	325	1,087	N/A
9/30/2023	4,141	-572	116	1,153	N/A
6/30/2023	3,853	-803	59	1,074	N/A
3/31/2023	3,465	-823	-650	891	N/A
1/1/2023	2,711	-1,177	-727	461	N/A
9/30/2022	2,786	-1,064	-940	294	N/A
6/30/2022	2,683	-1,058	-1,269	176	N/A
3/31/2022	2,594	-1,068	-832	184	N/A
12/31/2021	2,921	-822	-1,203	456	N/A
9/30/2021	2,583	-41	-1,096	374	N/A
6/30/2021	2,273	30	-1,174	379	N/A
3/31/2021	1,964	52	-1,401	252	N/A
12/31/2020	1,607	45	-1,297	41	N/A
9/30/2020	1,391	-882	-2,168	-285	N/A
6/30/2020	1,188	-753	-2,627	-422	N/A
3/31/2020	1,046	-622	-3,378	-313	N/A
12/31/2019	991	-404	-3,647	-34	N/A
9/30/2019	896	-68	-3,460	128	N/A
6/30/2019	872	-19	-3,775	-554	N/A
3/31/2019	1,108	2,193	-3,010	-622	N/A
12/31/2018	2,039	2,184	-2,471	-772	N/A
9/30/2018	2,973	2,244	-1,607	-496	N/A
6/30/2018	3,617	2,280	N/A	203	N/A
3/31/2018	4,130	152	N/A	424	N/A
12/31/2017	4,060	195	N/A	384	N/A
9/30/2017	4,024	190	N/A	335	N/A
6/30/2017	3,984	191	N/A	395	N/A
3/31/2017	3,944	214	N/A	415	N/A
12/31/2016	3,931	202	N/A	439	N/A
9/30/2016	3,872	260	N/A	362	N/A
6/30/2016	3,866	217	N/A	350	N/A
3/31/2016	3,866	197	N/A	260	N/A
12/31/2015	3,900	241	N/A	274	N/A
9/30/2015	3,927	328	N/A	262	N/A
6/30/2015	3,960	369	N/A	292	N/A
3/31/2015	3,929	382	N/A	318	N/A
12/31/2014	3,883	350	N/A	306	N/A
9/30/2014	3,786	213	N/A	399	N/A
6/30/2014	3,645	168	N/A	337	N/A
3/31/2014	3,604	142	N/A	241	N/A
12/31/2013	3,566	122	N/A	328	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 000516 önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.8% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: 000516 önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: 000516 önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: 000516 şirketinin gelirinin (yıllık 21.6% ) CN pazarından (yıllık 13.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 000516 şirketinin gelirinin (yıllık 21.6% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 000516 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 8.2 %).

Xi'an International Medical Investment Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt

Third quarter 2024 earnings released: CN¥0.018 loss per share (vs CN¥0 in 3Q 2023)

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Xi'an International Medical Investment Company Limited to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: CN¥0.03 loss per share (vs CN¥0.065 loss in 2Q 2023)

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Xi'an International Medical Investment Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Xi'an International Medical Investment Company Limited (SZSE:000516) commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on May 20, 2024.

Xi'an International Medical Investment Company Limited, Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: CN¥0.046 loss per share (vs CN¥0.033 loss in 1Q 2023)

Xi'an International Medical Investment Company Limited to Report Q1, 2024 Results on Apr 26, 2024

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Xi'an International Medical Investment Company Limited to Report Fiscal Year 2023 Results on Apr 26, 2024

Xi'an International Medical Investment Company Limited(SZSE:000516) dropped from Shenzhen Stock Exchange Component A Share Index

Third quarter 2023 earnings released: EPS: CN¥0 (vs CN¥0.10 loss in 3Q 2022)

Xi'an International Medical Investment Company Limited to Report Q3, 2023 Results on Oct 27, 2023

Second quarter 2023 earnings released: CN¥0.065 loss per share (vs CN¥0.074 loss in 2Q 2022)

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: CN¥0.033 loss per share (vs CN¥0.19 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.10 loss per share (vs CN¥0.099 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.074 loss per share (vs CN¥0.072 loss in 2Q 2021)

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Xi'an International Medical Investment Company Limited(SZSE:000516) dropped from Shenzhen Stock Exchange Component Index

Xi'an International Medical Investment Company Limited(XSEC:000516) dropped from FTSE All-World Index (USD)

Third quarter 2021 earnings released: CN¥0.099 loss per share (vs CN¥0.08 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.072 loss per share (vs CN¥0.079 loss in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.03 (vs CN¥0.21 loss in FY 2019)

New 90-day high: CN¥13.03

New 90-day high: CN¥9.25

New 90-day high: CN¥8.60

Third quarter earnings released

New 90-day high: CN¥7.87

New 90-day high: CN¥7.52

New 90-day high: CN¥7.04

First half earnings released

Xi'an International Medical Investment Company Limited to Report First Half, 2020 Results on Aug 28, 2020

Xi'an International Medical Investment Company Limited announced that it expects to receive CNY 1 billion in funding from Shaanxi Century Xinyuan Commercial Management Co., Ltd.

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin